ProfileGDS4459 / ENSG00000198315
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 51% 55% 66% 61% 70% 65% 51% 75% 63% 61% 69% 68% 66% 36% 63% 50% 52% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 14.4751
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 24.5855
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 35.1166
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 44.8761
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 55.3570
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 65.0265
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 74.4851
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 85.7375
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 94.9863
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 104.9261
GSM623474group B, liver allograft wedge biopsie placebo treatment 15.1969
GSM623475group B, liver allograft wedge biopsie placebo treatment 25.2768
GSM623476group B, liver allograft wedge biopsie placebo treatment 35.1466
GSM623477group B, liver allograft wedge biopsie placebo treatment 43.9836
GSM623478group B, liver allograft wedge biopsie placebo treatment 54.9963
GSM623479group B, liver allograft wedge biopsie placebo treatment 64.450
GSM623480group B, liver allograft wedge biopsie placebo treatment 74.4652